Gadobutrol is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer Schering Pharma as Gadovist, and by Bayer HealthCare Pharmaceuticals as Gadavist.
Wang, Chungui; Guo, Shuai; Zhang, Xuyang; Huo, Xianghong; Wang, Qi; Wang, Lichun; Wang, Jingyi. Method for preparing gadobutrol. Assignee Tianjin Kelun Pharmaceutical Research Co., Ltd., Peop. Rep. China; Sichuan Kelun Pharmaceutical Research Co., Ltd. CN 109293592. (2019).
Long, Xiangtian; Tan, Junrong; Lu, Biao; Lai, Yingjie; Liang, Long; Xie, Dexun. Method for preparing high purity Gadobutrol. Assignee Chem-Stone Co., Ltd., Peop. Rep. China. CN 108299322. (2018).
Long, Xiangtian; Zhou, Lei; Lai, Yingjie; Bai, Libin; Cao, Benwen; Tan, Junrong; Liang, Long; Xie, Dexun. Method for preparing high-yield gadobutrol using tetraazacyclododecane monoformaldehyde. Assignee Chem-Stone Co., Ltd., Peop. Rep. China. CN 108047151. (2018).
Yuan, Jinqiao; Zhu, Laifa; Liu, Hu. Preparation method of high-purity gadobutrol. Assignee Jiashi (Hunan) Pharmaceutical Technology Co., Ltd., Peop. Rep. China. CN 106543094. (2017).
Zhu, Quan; Shi, Xinghua; Zheng, Zhaoguang; Ou, Xiaomin; Tang, Dan; Wang, Rushang; Gu, Fei; He, Bao; Duan, Tingting; Cheng, Huiquan; Huang, Xiaoling; Huang, Yunbin; Huang, Yanxia; Chen, Yuling. Method for preparing contrast agents for magnetic resonance imaging. Assignee Guangzhou Consun Pharmaceutical Research Co., Ltd., Peop. Rep. China. CN 102399199. (2012).
Argese, Maria; Ripa, Giorgio. Preparation of 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one for the preparation of tetraazamacrocycles. Assignee Bracco S.P.A., Italy; Dibra S.P.A. WO 9905145. (1999).
